The report provides market dynamics and trends related to the global oncology/ cancer drugs market. In addition, it presents the market estimations and forecast of the market. The study estimates revenue generated from the sales of different form of oncology drugs such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. The report covers revenue generated from drugs for various cancer conditions such as lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and others. The report does not include revenue generated from supportive drugs used during cancer treatment, for instance, anti-nauseous drugs, pain killers, and others. Moreover, the report excludes revenue generated from post-sale services of oncology/cancer drugs market.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ONCOLOGY/CANCER DRUGS MARKET, BY DRUG CLASS TYPE

CHAPTER 5: ONCOLOGY/ONCOLOGY/CANCER DRUGS MARKET, BY INDICATIION

CHAPTER 6: ONCOLOGY/CANCER DRUGS MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES